Cutaneous mucormycosis by Rhizopus arrhizus treated with isavuconazole as first line therapy: A case report
Medical Mycology Case Reports(2019)
Abstract
Mucormycosis are a group of infections that affect principally immunocompromised host and have a high mortality. Liposomal amphotericin B is the first-line treatment with combined surgical removal of the infectious focus. We report the case of 67-year-old man with idiopathic granulocytic aplasia and a cutaneous lesion caused by Rhizopus arrhizus treated with isavuconazole. Its safety profile and spectrum of activity make it an important therapeutic option.
MoreTranslated text
Key words
Mucormycosis,Cutaneous,Immunocompromised,Isavuconazole
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined